Inventor profile of:

Bertram Jacobs

City:

Tempe, Arizona

Country:

United States

Published Applications:

28

Last publication date:

2025-08-21

Top Assignees for applications by Bertram Jacobs

The entities that hold a legal rights for patent applications filed by inventor Jacobs Bertram:

Recent patent applications by Jacobs Bertram

Bertram Jacobs from Tempe, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-08-21
US20250262263A1
Human necessities

METHOD AND COMPOSITIONS FOR THE USE OF BOTANICAL EXTRACTS IN THE TREATMENT OF VIRAL INFECTIONS

#2 | 2024-07-11
US20240226273A1
Human necessities

Highly Attenuated Replication-Competent Recombinant Poxvirus As A Vaccine Platform And Methods Of Use

#3 | 2024-07-11
US20240226220A9
Human necessities

ORAL BOTANICAL COMPOSITION

#4 | 2024-04-25
US20240131104A1
Human necessities

ORAL BOTANICAL COMPOSITION

#5 | 2022-03-24
US20220088178A1
Human necessities

HIV vaccination compositions comprising vaccinia VLPS and plant-produced VLPS presenting HIV antigens

#6 | 2022-03-03
US20220062365A1
Human necessities

METHOD AND COMPOSITIONS FOR THE USE OF BOTANICAL EXTRACTS IN THE TREATMENT OF VIRAL INFECTIONS

#7 | 2021-09-09
US20210275620A1
Human necessities

METHOD AND COMPOSITIONS FOR THE USE OF BOTANICAL EXTRACTS IN THE TREATMENT OF VIRAL INFECTIONS

#8 | 2020-06-04
US20200171331A1
Human necessities

Pharmaceutical compositions comprising caffeic acid chelates

#9 | 2019-10-31
US20190328864A1
Human necessities

HIV VACCINATION COMPOSITIONS

#10 | 2019-08-01
US20190231836A1
Human necessities

Method for the use of botanical extracts in the treatment of viral infections

#11 | 2019-06-20
US20190183947A1
Human necessities

Oncolytic vaccinia virus mutants and using same for cancer treatment

#12 | 2018-11-08
US20180318373A1
Human necessities

Methods of using extracts of melissa officinalis against filoviruses

#13 | 2018-07-19
US20180200320A1
Human necessities

METHOD AND COMPOSITIONS FOR THE USE OF BOTANICAL EXTRACTS IN THE TREATMENT OF VIRAL INFECTIONS, CANCER, PAIN, ITCH, AND INFLAMMATION

#14 | 2017-01-26
US20170021009A1
Human necessities

Heat Inactivated Poxvirus Improves Vaccination Results

#15 | 2015-08-27
US20150240246A1
Chemistry; metallurgy

Temperature-dependent insertion of genetic material into genomic DNA

#16 | 2014-12-25
US20140377870A1
Chemistry; metallurgy

METHOD FOR INSERTING GENETIC MATERIAL INTO GENOMIC DNA

#17 | 2014-09-11
US20140255990A1
Chemistry; metallurgy

Genetic element that enhances protein translation

#18 | 2014-07-10
US20140193859A1
Chemistry; metallurgy

Temperature-dependent insertion of genetic material into genomic DNA

#19 | 2013-11-07
US20130295675A1
Chemistry; metallurgy

METHOD FOR INSERTING GENETIC MATERIAL INTO GENOMIC DNA

#20 | 2013-09-05
US20130230884A1
Chemistry; metallurgy

Methods to Identify Synthetic and Natural RNA Elements that Enhance Protein Translation

#21 | 2012-12-27
US20120328653A1
Chemistry; metallurgy

Modified immunization vectors

#22 | 2011-06-16
US20110142874A1
Human necessities

Compositions, Methods, and Kits for Eliciting an Immune Response

#23 | 2007-02-15
US20070036758A1
Chemistry; metallurgy

Mutants of vaccinia virus as oncolytic agents

#24 | 2006-09-28
US20060216312A1
Chemistry; metallurgy

Mutants of replication competent vaccinia virus

#25 | 2006-05-11
US20060099181A1
Chemistry; metallurgy

Viral vectors having reduced virulence

#26 | 2006-01-12
US20060008470A1
Chemistry; metallurgy

Use of vaccinia virus deleted for the E3L gene as a vaccine vector

#27 | 2005-02-24
US20050042206A1
Chemistry; metallurgy

Viral vectors having reduced virulence

#28 | 2005-01-25
US9887295
-

Viral vectors having enhanced effectiveness with reduced virulence

InventorID:

424751 ⎘